Association of PON1 Haplotypes (Q192R and L55M) with the Severity of Coronary Atherosclerosis
International Journal of Molecular Sciences · 14.08.2026 · 27 (16) · 7241
DOI: 10.3390/ijms27167241 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.08.2026. Verfasst von Mariola Rychlik-Sych und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, Laboratory of Pharmacogenetics, Chair of Biopharmacy, Medical University of Lodz, 90-151 Łódź, Poland. Hauptthemen laut MEDLINE: Aryldialkylphosphatase, Haplotypes, Coronary Artery Disease, Genetic Predisposition to Disease. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.
Abstract (Originalsprache)
Enzyme paraoxonase 1 (PON1) plays a protective role against atherosclerosis by preventing the oxidation of low-density lipoproteins (LDL). Polymorphisms in the PON1, particularly Q192R and L55M, have been shown to affect the enzyme activity and, consequently, the cardiovascular risk. The present study aimed to evaluate the association between PON1 haplotypes comprising the Q192R and L55M polymorphisms and the severity of coronary atherosclerosis in a Polish population. The retrospective study involved 282 individuals of both sexes, divided into two groups following coronarography. The study group included patients after PCI (percutaneous coronary intervention) with stent implantation or patients who qualified for CABG (coronary artery bypass graft), with stenoses of minimum 70% (n = 140), whereas the control group included those after coronarography and without essential lesions in coronary vessels (n = 142). The Q192R PON1 polymorphism was identified by PCR-RFLP. The haplotypes 192R-55L and 192R-55M have been shown to be statistically significantly associated with a higher risk of atherosclerosis that requires PCI/CABG (OR = 2.06, 95% CI: 1.29–3.28, p = 0.0022; OR = 1.77, 95% CI: 1.17–2.69, p = 0.007; respectively). Furthermore, the risk of atherosclerosis requiring PCI or CABG was 53% lower in patients with the 192Q-55L haplotype (OR = 0.47, 95% CI: 0.34–0.66, p = 0.000013). Haplotypes 192R-55L and 192R-55M may increase the risk of atherosclerosis requiring PCI/CABG, whereas the 192Q-55L haplotype may lower the risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hospital Pharmacy, Laboratory of Pharmacogenetics, Chair of Biopharmacy, Medical University of Lodz, 90-151 Łódź, Poland.
ORCID-Profile: Mariola Rychlik-Sych, Małgorzata Barańska, Michał Dudarewicz, Jacek Owczarek
Förderung
- Medical University of Lodz
Zitieren
APA
Rychlik-Sych, M., Barańska, M., Dudarewicz, M., & Owczarek, J. (2026). Association of PON1 Haplotypes (Q192R and L55M) with the Severity of Coronary Atherosclerosis. International Journal of Molecular Sciences, 27(16), 7241. https://doi.org/10.3390/ijms27167241
Vancouver
Rychlik-Sych M, Barańska M, Dudarewicz M, Owczarek J. Association of PON1 Haplotypes (Q192R and L55M) with the Severity of Coronary Atherosclerosis. International Journal of Molecular Sciences. 2026;27(16):7241. doi:10.3390/ijms27167241
BibTeX
@article{RychlikSych2026,
author = {Rychlik-Sych, Mariola and Barańska, Małgorzata and Dudarewicz, Michał and Owczarek, Jacek},
title = {Association of PON1 Haplotypes (Q192R and L55M) with the Severity of Coronary Atherosclerosis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {16},
pages = {7241},
doi = {10.3390/ijms27167241}
}
EUVIMED